Benign Prostatic Hyperplasia Companies

This report lists the top Benign Prostatic Hyperplasia companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Benign Prostatic Hyperplasia industry.

Benign Prostatic Hyperplasia Top Companies

  1. Abbvie

  2. Eli Lilly and Company

  3. Merck

  4. Boehringer Ingelheim

  5. Astellas Pharma

*Disclaimer: Top companies sorted in no particular order

Benign Prostatic Hyperplasia Market Major Players

Benign Prostatic Hyperplasia Market Concentration

Benign Prostatic Hyperplasia Market Concentration

Benign Prostatic Hyperplasia Company List

  • Allergan PLC

  • Astellas Pharma Inc.

  • Boehringer Ingelheim

  • Eli Lilly and Company

  • GlaxoSmithKline PLC

  • Nymox Pharmaceutical Corporation

  • Pfizer Inc

  • Sanofi

  • Sophiris Bio Corp

  • Teva Pharmaceutical Industries Limited


Specific to Benign Prostatic Hyperplasia Market
Need More Details on Market Players and Competitors?
Download PDF

Benign Prostatic Hyperplasia Market Report Snapshots

Access Report long-arrow-right